Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Protein aggregation and proteasome dysfunction after brain ischemia.

Pengfei Ge1, Yinan Luo, Cindy L Liu

  • 1Department of Neurosurgery, First Teaching Hospital, Jilin University, Jilin, China.

Stroke
|November 3, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Feasibility of a Multi-Laboratory Model of Middle Cerebral Artery Thromboembolic Stroke with Thrombolysis: TE-MCAo.

Translational stroke research·2026
Same author

The Stroke Preclinical Assessment Network Multi-laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo.

Journal of visualized experiments : JoVE·2026
Same author

Microglia-specific interleukin-4 delivery by engineered extracellular vesicles restores inner blood-retinal barrier in diabetic retinopathy via GAS6-MERTK pathway.

Journal of nanobiotechnology·2025
Same author

Omeprazole-mediated nanodelivery of copper for synchronous remodeling of copper influx and efflux in cuproptotic glioblastoma therapy.

Acta biomaterialia·2025
Same author

An Integrated Multi-Omics Analysis Identifies Oxeiptosis-Related Biomarkers in Diabetic Retinopathy.

Biomedicines·2025
Same author

From mechanism to targeted therapy: Advances in histone lactylation-driven cancer progression (Review).

Oncology letters·2025
Same journal

Loss of Pericytic Integrin-β1 Exacerbates Blood-Brain Barrier Damage and Hemorrhagic Brain Injury.

Stroke·2026
Same journal

MAD-MT Score: A Tool to Optimize Patient Selection for Mechanical Thrombectomy in Distal Vessel Occlusions.

Stroke·2026
Same journal

Threshold Effects, Cognitive Decline, and Longitudinal Changes in White Matter Hyperintensity Volume.

Stroke·2026
Same journal

PREVENT Equations: Implications for Stroke Prevention.

Stroke·2026
Same journal

Defining the Therapeutic Ceiling of Endovascular Thrombectomy in Large-Core Stroke: Beyond the Limits of ASPECTS.

Stroke·2026
Same journal

Adjunctive Normobaric Hyperoxia With Endovascular Thrombectomy for Acute Stroke at 6 to 24 Hours: A Phase IIb Randomized Trial.

Stroke·2026
See all related articles

Brain ischemia causes proteasome dysfunction, leading to protein aggregation. Proteasomes disassemble and aggregate, failing to degrade overproduced proteins after ischemic events.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Protein unfolding and aggregation are key early pathogenic events in neurons following brain ischemia.
  • This study investigates the link between unfolded protein overproduction and proteasome dysfunction after ischemic injury.

Purpose of the Study:

  • To determine if the overproduction of unfolded proteins after brain ischemia is a result of impaired proteasome function.
  • To investigate proteasome dysfunction in a transient cerebral ischemia model.

Main Methods:

  • Assessed proteasome peptidase activity using a specific peptide substrate.
  • Utilized Western blot analysis and size-exclusion chromatography to study proteasome assembly and subcellular redistribution.

Main Results:

Related Experiment Videos

  • Proteasome peptidase activity was moderately decreased post-ischemia.
  • The 26S proteasome disassembled during early reperfusion following transient brain ischemia.
  • Proteasome subunits, especially 19S components, were found in protein aggregate fractions.

Conclusions:

  • Brain ischemia leads to proteasome disassembly and aggregation, impairing normal function.
  • Proteasomes may attempt to degrade overproduced ubiquitin-conjugated proteins but become trapped in aggregates due to their sheer number.